The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer

por Ragnum, H B, Vlatkovic, L, Lie, A K, Axcrona, K, Julin, C H, Frikstad, K M, Hole, K H, Seierstad, T, Lyng, H
Publicado 2015